May 21, 2004 – LAWFUEL – Allen & Overy is advising Celltech Group…

May 21, 2004 - LAWFUEL - Allen & Overy is advising Celltech Group plc, the leading UK-based biotechnology company, on the £1.53 billion recommended offer by Belgian company UCB S.A., announced today. The 550 pence per share cash deal will create a bio-pharmaceutical leader in Europe, and one of the largest biopharmaceutical companies in the world. The Allen & Overy team is led by corporate partners David Wootton and Anna Buscall, assisted by Alun Eynon-Evans. Daniel Epstein and Mandy DeFilippo advised on US aspects. Allen & Overy (corporate partner Colleen Keck) also advised Celltech on its collaboration agreement with UCB relating to CDP 870, also announced today. Commenting on the transaction, David Wootton said: "We worked closely with Celltech's teams to help bring this transaction together. Our longstanding relationship with Celltech, and knowledge of Celltech's business, was invaluable in the process. This will obviously be an important transaction in the pharma/bio sector as biotechnology firms strive for global reach." Morgan Stanley and JP Morgan are acting as financial advisers to Celltech. For further information, please contact Claire Meeghan >claire.meeghan@allenovery.com) in London on +44 (0) 20 7330 2395.

May 21, 2004 – LAWFUEL – Allen & Overy is advising Celltech Group…

About The Author

Law Admin

Subscibe to LawFuel

About The Author

Law Admin

Read More